Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 236

Работа: Advancements in risk stratification and management strategies in primary cardiovascular prevention

  1. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M. Ridker, Brendan M. Everett, Tom Thurén +25

    Статья2017Цитирований: 2
    ABI

  2. A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins

    Tetsu Watanabe, Kaoru Ando, Hyuma Daidoji +14

    Статья2017Цитирований: 2
    ABI

  3. Clinical Genetic Testing for Familial Hypercholesterolemia

    Amy C. Sturm, Joshua W. Knowles, Samuel S. Gidding +29

    Обзорная статья2018Цитирований: 2
    ABI

  4. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk

    Pratik B. Sandesara, Salim S. Virani, Sergio Fazio +1

    Обзорная статья2018Цитирований: 2
    ABI

  5. Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis

    Francesco Potì, Daniele Santi, Giorgia Spaggiari +2

    Обзорная статья2019Цитирований: 2
    ABI

  6. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

    Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert +15

    Обзорная статья2019Цитирований: 2
    ABI

  7. Artificial Intelligence in Cardiovascular Imaging

    Damini Dey, Piotr J. Slomka, Paul Leeson +4

    Обзорная статья2019Цитирований: 2
    ABI

  8. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97

    Статья2019Цитирований: 2
    ABI

  9. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    Jean‐Claude Tardif, Simon Kouz, David D. Waters +22

    Статья2019Цитирований: 2
    ABI

  10. Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease

    Mark Trinder, Gordon A. Francis, Liam R. Brunham

    Статья2020Цитирований: 2
    ABI

  11. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén, M. John Chapman, Ronald M. Krauss +27

    Статья2020Цитирований: 2
    ABI

  12. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

    Kausik K. Ray, R. Scott Wright, David Kallend +8

    Статья2020Цитирований: 2
    ABI

  13. Colchicine in Patients with Chronic Coronary Disease

    Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd +30

    Статья2020Цитирований: 2
    ABI

  14. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

    Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia +19

    Статья2020Цитирований: 2
    ABI

  15. Heart Disease and Stroke Statistics—2021 Update

    Salim S. Virani, Álvaro Alonso, Hugo J. Aparicio +36

    Статья2021Цитирований: 2
    ABI

  16. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

    Steven H J Hageman, Lisa Pennells, Francisco Ojeda +97

    Статья2021Цитирований: 2
    ABI

  17. Familial Hypercholesterolemia

    Julia Brandts, Kausik K. Ray

    Обзорная статья2021Цитирований: 2
    ABI

  18. Managing Atherosclerotic Cardiovascular Risk in Young Adults

    Neil J. Stone, Sidney C. Smith, Carl E. Orringer +9

    Обзорная статья2022Цитирований: 2
    ABI

  19. Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis

    Alma Zernecke, Florian Erhard, Tobias Weinberger +4

    Статья2022Цитирований: 2
    ABI

  20. New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing

    Reindert F. Oostveen, Amit V. Khera, Sekar Kathiresan +5

    Обзорная статья2023Цитирований: 2
    ABI

  21. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

    Ania M. Jastreboff, Lee M. Kaplan, Juan P. Frías +7

    Статья2023Цитирований: 2
    ABI

  22. The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist

    Yun Kyung Cho, Yoo La Lee, Chang Hee Jung

    Обзорная статья2023Цитирований: 2
    ABI

  23. Без названия

    ДругоеЦитирований: 1
    ABI

  24. Без названия

    ДругоеЦитирований: 1
    ABI

  25. Без названия

    ДругоеЦитирований: 1
    ABI